LRRC69
Leucine-rich repeat-containing protein 69
Also known as: LRC69_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZNQ3
- Gene
- LRRC69
- Ensembl
- ENSG00000214954
- Chromosome
- 8
- Canonical length
- 347 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Predicted to be involved in intracellular signal transduction. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
347 residues, UniProt reviewed canonical sequence.
>Q6ZNQ3|LRRC69
1 MTERLLIKAL SGGKNTKIIT LNGKKMTKMP SALGKLPGLK TLVLQNNLIP KVCPELCNLT
61 QLTTLNLGNN LLEEVPEEMK YLTSLKNLHL SGNRICRFAP GACDGLQNLI LLNLNNNHLT
121 QLPQEVSRLK SLTYMSINYN QLASIPRELC FLENLVELQL NYNQLICIPE EIKFLKKLQK
181 LLLARNNIGV LPEELCDLKK LRILDIAGNI IQIFPSGFQD LKLREFYCEG NPLFLQQPVI
241 STQQENVWSL QEITSRFVMN QLAENNPFLM DDIERYPQVR SMISQGKTCA ICGQYFITVW
301 LECVRFVPPP KDWKISKNLK LVPLQVLICS YKCFTQRDPN LFGIAQVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRC69 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 2.7 nTPM
Expression across tissuesHPA
Tissue
- testis: 2.7 nTPM
- skin: 1.4 nTPM
- lymph node: 0.8 nTPM
- parathyroid gland: 0.8 nTPM
- appendix: 0.7 nTPM
- smooth muscle: 0.7 nTPM
Single-cell type
- late primary spermatocytes: 101 nCPM
- adrenal cortex cells: 69 nCPM
- microglia: 63 nCPM
- ependymal cells: 57 nCPM
- choroid plexus epithelial cells: 52 nCPM
- adipocytes: 41 nCPM
Immune cell
- T-reg: 0.5 nTPM
- naive B-cell: 0.4 nTPM
- naive CD4 T-cell: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
- eosinophil: 0.3 nTPM
- memory CD4 T-cell: 0.3 nTPM
Brain region
- white matter: 2.6 nTPM
- choroid plexus: 2.4 nTPM
- medulla oblongata: 2.3 nTPM
- pons: 2.1 nTPM
- basal ganglia: 1.8 nTPM
- cerebellum: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.6
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRC69 as an antibody target. Whether an autoantibody or antibody against LRRC69 could matter depends on whether native LRRC69 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRC69 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRRC69 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...